Greetings!
Media Advisory: Ethics & Biopharmaceutical R&D: Who Should Be Responsible for Tomorrow's Drugs? Panel exploring balancing profit, public health and trust. Description: Under the current market-based system, some critics argue that pharmaceutical companies have financial incentives to support R&D that will yield the biggest return but that may not be in the best interests of improving the health of patients worldwide. They claim, for example, that pharmaceutical companies are far more interested in producing Viagra than filling unmet medical needs, and call for a change in paradigm of drug design and provision. Others point to the high costs of R&D and the critical importance of blockbuster drugs to the future development of less-profitable vaccines and antibiotics; without the former, they argue, there could be no breakthroughs.
Only 11 % of Americans trust drug companies, ranked barely above oil & tobacco companies. Can ethics improve conduct and trust? WHO: - Jennifer Miller, MS, PhD Cand - Chair Executive Director , Bioethics International - Richard Hubbard, MD, MD, Senior Director, External Medical Affairs, Pfizer Inc. - Stephen Latham, PhD Deputy Director, Interdisciplinary Center for Bioethics YALE - Ellen Strahlman, MD Senior Vice President, Chief Medical Officer GlaxoSmithKline - Melinda Moree, CEO BIO Ventures for Global Health WHEN: Today - Thursday, May 6, 2010 2:00 PM - 3:30 PM WHERE: Room: S403A, McCormick Place, Chicago About BIOETHICS INTERNATIONAL BIOETHICS INTERNATIONAL (BEI) Is the leading U.S. provider of disaster preparedness and person-centered bioethics programs for the global healthcare sector. BEI empowers responsible, person-centered, and trustworthy healthcare decision-making and innovation - key to improving the quality of healthcare, public health, lives, and international human rights - through education, training and advisory services on a diverse spectrum of bioethical issues. About BIO BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. Contact Jennifer Miller Bioethics International |
